ATE200709T1 - Htlv-i/htlv-ii assay und verfahren - Google Patents

Htlv-i/htlv-ii assay und verfahren

Info

Publication number
ATE200709T1
ATE200709T1 AT93906091T AT93906091T ATE200709T1 AT E200709 T1 ATE200709 T1 AT E200709T1 AT 93906091 T AT93906091 T AT 93906091T AT 93906091 T AT93906091 T AT 93906091T AT E200709 T1 ATE200709 T1 AT E200709T1
Authority
AT
Austria
Prior art keywords
htlv
kit
peptide antigens
hltv
infection
Prior art date
Application number
AT93906091T
Other languages
English (en)
Inventor
Steven K H Foung
Kenneth G Hadlock
Theresa P Chow
Original Assignee
Genelabs Tech Inc
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc, Univ Leland Stanford Junior filed Critical Genelabs Tech Inc
Application granted granted Critical
Publication of ATE200709T1 publication Critical patent/ATE200709T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93906091T 1992-02-24 1993-02-19 Htlv-i/htlv-ii assay und verfahren ATE200709T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84090692A 1992-02-24 1992-02-24
PCT/US1993/001498 WO1993017341A1 (en) 1992-02-24 1993-02-19 Htlv-i/htlv-ii assay and method

Publications (1)

Publication Number Publication Date
ATE200709T1 true ATE200709T1 (de) 2001-05-15

Family

ID=25283539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93906091T ATE200709T1 (de) 1992-02-24 1993-02-19 Htlv-i/htlv-ii assay und verfahren

Country Status (10)

Country Link
US (1) US6110662A (de)
EP (1) EP0643835B1 (de)
JP (1) JP3506252B2 (de)
AT (1) ATE200709T1 (de)
CA (1) CA2117378C (de)
DE (1) DE69330164T2 (de)
ES (1) ES2159291T3 (de)
GR (1) GR3036218T3 (de)
PT (1) PT643835E (de)
WO (1) WO1993017341A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
EP0702516A4 (de) * 1993-06-01 1998-04-22 Life Technologies Inc Genetische immunisierung mit kationischen lipiden
EP0736179A1 (de) * 1993-12-20 1996-10-09 Abbott Laboratories Differenzierung von htlv-i und htlv-ii unter verwendung synthetischer peptide
US6989434B1 (en) * 1994-02-11 2006-01-24 Invitrogen Corporation Reagents for intracellular delivery of macromolecules
WO1996013608A2 (en) * 1994-10-28 1996-05-09 Innogenetics N.V. Polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
EP1129064B1 (de) 1998-11-12 2008-01-09 Invitrogen Corporation Transportreagentien
US8158405B2 (en) * 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
WO2015068715A1 (ja) 2013-11-06 2015-05-14 富士レビオ株式会社 抗htlv抗体の免疫測定における非特異反応の低減方法
EP2913338A1 (de) * 2014-02-28 2015-09-02 Roche Diagniostics GmbH Lösliche und immunoreaktive Varianten von HTLV-Antigen-Kapsid P24
WO2016011203A1 (en) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions with lipid aggregates and methods for efficient delivery of molecules to cells

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE71150T1 (de) * 1984-09-19 1992-01-15 Univ California Retrovirale polypeptide in zusammenhang mit menschlicher transformation.
GB8607101D0 (en) * 1986-03-21 1986-04-30 Serono Diagnostics Ltd Immunoassay
JPS62296889A (ja) * 1986-05-14 1987-12-24 Fujirebio Inc Htlv−i抗原活性を有する蛋白及びその製造法
JP2501569B2 (ja) * 1986-11-14 1996-05-29 協和醗酵工業株式会社 抗成人t細胞白血病ウイルス抗体の検出法
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5066579A (en) * 1986-12-31 1991-11-19 Genelabs Incorporated HTLV-I peptide antigen and assay
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
US5003043A (en) * 1988-05-25 1991-03-26 Triton Biosciences Inc. Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof
EP0404935B1 (de) * 1989-01-13 1995-01-04 United Biomedical Inc. Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
JP2525054B2 (ja) * 1989-08-01 1996-08-14 株式会社トクヤマ 成人t細胞白血病ウィルス感染診断薬
US5283320A (en) * 1989-11-13 1994-02-01 Syntello Ab Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
FI910245L (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
NZ238855A (en) * 1990-07-18 1994-03-25 Iaf Biochem Int Peptides, mixtures thereof and compositions useful for detecting htlv-i and htlv-ii infections
US5359029A (en) * 1990-07-18 1994-10-25 Biochem Immunosystems Inc. Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-I and HTLV-II viruses
EP0551308A4 (en) * 1990-08-29 1994-09-14 Us Health Novel peptide antigens and immunoassays, test kits and vaccines using the same
JPH04164097A (ja) * 1990-10-24 1992-06-09 Kuraray Co Ltd ペプチドおよびその用途
DK0677117T3 (da) * 1991-07-10 1999-11-29 Abbott Lab Sondring mellem HTLV-I og HTLV-II under anvendelse af syntetiske peptider
WO1993002102A1 (en) * 1991-07-23 1993-02-04 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Novel peptide antigens and immunoassays, test kits and vaccines using the same
AU2879292A (en) * 1991-10-08 1993-05-03 Duke University Peptides corresponding to antigenic determinants of htlv
EP0573630A4 (de) * 1991-11-25 1995-07-12 Baxter Diagnostics Inc Immunoassay unter verwendung von synthetischen htlv-ii-peptiden.

Also Published As

Publication number Publication date
PT643835E (pt) 2001-10-30
CA2117378C (en) 2003-04-15
EP0643835A1 (de) 1995-03-22
GR3036218T3 (en) 2001-10-31
HK1013328A1 (en) 1999-08-20
DE69330164T2 (de) 2002-01-17
JP3506252B2 (ja) 2004-03-15
EP0643835B1 (de) 2001-04-18
EP0643835A4 (de) 1996-04-03
WO1993017341A1 (en) 1993-09-02
ES2159291T3 (es) 2001-10-01
US6110662A (en) 2000-08-29
DE69330164D1 (de) 2001-05-23
JPH07504036A (ja) 1995-04-27
CA2117378A1 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
ATE282828T1 (de) Schnelltest zur gleichzeitigen spezifischen bestimmung von hiv-antikörpern
AU720123B2 (en) Antigen-specific IgM detection
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
ATE98700T1 (de) Anti-fr-900506-stoffe-antikoerper und hoechstempfindliches enzym-immunoassay-verfahren.
ATE223575T1 (de) Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung
CA2272369A1 (en) Antigen-specific igg detection
ATE200709T1 (de) Htlv-i/htlv-ii assay und verfahren
ATE190728T1 (de) Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper
RU2213973C2 (ru) СПОСОБ ОПРЕДЕЛЕНИЯ АНТИБИОТИКОВ, СОДЕРЖАЩИХ β-ЛАКТАМНЫЙ ЦИКЛ, В ЖИДКОСТИ БИОЛОГИЧЕСКОГО ПРОИСХОЖДЕНИЯ И АНАЛИТИЧЕСКИЙ НАБОР ДЛЯ ЕГО ОСУЩЕСТВЛЕНИЯ
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
JPH11511851A (ja) 細胞計数イムノアッセイ
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
ATE324590T1 (de) System und verfahren für immunologische assays
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
NZ334809A (en) Assay for the detection of antibodies against p53
DE69512909D1 (de) Festphasen-filtrationsverfahren zur antigen- und antikörperprüfung in der blutgruppen-serologie, und testsatz
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
Levine et al. Fast ELISA for measuring serum antibody responses
CA2550264A1 (en) Method and device for detecting feline immunodeficiency virus
JPH08114595A (ja) 特異的結合測定法
DE3853282D1 (de) Diagnostischer Test für Pseudomonas Aeruginosa Infektionen.
UA66095A (en) IMMUNOENZYME ASSAY KIT FOR DETECTING IgG AGAINST HERPES VIRUSES TYPES I AND II IN HUMAN BLOOD SERUM (DIA-HSV 1/2-IgG)
GR1004300B (el) Νεα, ανοσοαναλυτικη, μεθοδος προσδιορισμου της φερομονης του δακου της ελιας

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties